KOREAN Enhanced RecOvery Strategy for Colorectal Surgery

NATerminatedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Goal-oriented Fluid TherapyColorectal Surgery
Interventions
OTHER

Combined epidural-general anesthesia (CEGA)

Combined epidural-general anesthesia (CEGA) will be used intraoperatively and patient-controlled epidural analgesia (PCEA) will be used postoperatively in a multimodal analgesic regimen.

DRUG

Volulyte® (6% HES 130/0.4 in balanced solution)

"For the SOC Group: Intraoperative fluid management includes Volulyte® (6% HES 130/0.4 in balanced solution) as the only colloid solution to be used, the daily dosage of Volulyte® is restricted to 50 ml/kg.~For the ERS Group:~GDFT regimen will be utilized using Volulyte® (6% HES 130/0.4 in balanced solution) during surgery. The daily dosage of Volulyte® is restricted to 50 ml/kg."

OTHER

Patient-Controlled Epidural Analgesia (PCEA)

For the ERS Group, patient-controlled epidural analgesia (PCEA) will be used postoperatively in a multimodal analgesic regimen.

Trial Locations (3)

135-710

Samsung Medical Center, Gangnam-Gu

Unknown

Yonsei University College of Medicine, Seodaemun-gu

138-736

Asan Medical Center, Songpa-gu

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duke University

OTHER

NCT01874730 - KOREAN Enhanced RecOvery Strategy for Colorectal Surgery | Biotech Hunter | Biotech Hunter